key: cord-0051816-xqsbn715 authors: nan title: Position Statement Regarding the Use and Exposure to Tobacco Products in Children, Adolescents, and Young Adults date: 2020-10-20 journal: J Pediatr Health Care DOI: 10.1016/j.pedhc.2020.07.007 sha: e1763024457897318afcb36358309522df1f7fe6 doc_id: 51816 cord_uid: xqsbn715 nan youth (defined as individuals aged 10−25 years) and pregnant women, should be avoided (HHS, 2016; Whittington et al., 2018) . Preventing youth tobacco product use is critical because nearly nine out of 10 adult smokers initiated use before the age of 18 years, and 98% initiated use before the age of 26 years (CDC, 2020b; HHS, 2014) . A tobacco product is any product containing, made of, or derived from tobacco or nicotine (Table) that is intended for human consumption, whether inhaled, absorbed, or ingested by any means (Food and Drug Administration, U.S. Department of Health and Human Services, 2016; Preventing Tobacco Addiction Foundation, 2019). Tobacco products have evolved in recent years to include additional smoked, smokeless, and electronic products (CDC, 2020a; Wang et al., 2019) . According to the National Youth Tobacco Survey (CDC, 2019a), 4.7 million (31.2%, nearly 1 in 3) high school students and 1.5 million middle school students (12.5%, 1 in 8) currently use tobacco products, erasing decades of progress in reducing youth tobacco use Wang et al., 2019) . Since 2014, electronic cigarettes (e-cigarettes; "vaping") have become the most common tobacco product used by youth. In 2019, e-cigarettes accounted for 27.5% of high school youth tobacco use, followed by cigars (7.6%), cigarettes (5.8%), smokeless tobacco (4.8%), hookah (3.4%), and pipe tobacco (1.1%; CDC, 2019a). The Monitoring the Future survey has measured drug and alcohol use and related attitudes among adolescent students nationwide since 1975 (National Institute on Drug Abuse, 2018). Between 2017 and 2018, the percentage of 12th graders who reported vaping nicotine during the past 30 days nearly doubled, representing the biggest year-to-year use increase of any substance in the 44-year history of the survey (National Institute on Drug Abuse, 2018). Because e-cigarettes are more loosely regulated than other combustible tobacco products, exposure to advertising, and the availability of flavorings have become significant factors driving youth use (Food and Drug Administration, U.S. Department of Health and Human Services, 2016). Studies have found that in-store, television, and social media advertising of e-cigarettes increases the likelihood of use by youth (Loukas et al., 2019) . Numerous studies have demonstrated that youth prefer fruit, mint, candy, or menthol flavors, and the use of flavors is associated with more puffs of vape products per occasion Nguyen, McKelvey, & Halpern-Felsher, 2019) . Nicotine exposure negatively impacts the developing human brain through a variety of mechanisms during pregnancy (Holbrook, 2016; Wong, Barra, Alfaidy, Hardy, & Holloway, 2015) . Exposure to tobacco products during pregnancy increases the risk of prematurity, low birth weight, birth defects of the mouth and lip, and sudden infant death syndrome (CDC, 2019b). The flavorings used in e-cigarettes may pose an additional risk to developing babies as chemicals in e-cigarette flavorings have been found to be cytotoxic to human embryonic stem cells (Bahl et al., 2012) . Nicotine also uniquely alters the adolescent brain with more significant damaging effects than nicotine exposure during adulthood (Yuan, Cross, Loughlin, & Leslie, 2015) . Nicotine exposure during adolescence can negatively impact learning, memory, attention, and impulse control and is associated with increased risk of mood disorders, including depression and anxiety (Dinardo & Rome, 2019; England, Bunnell, Pechacek, Tong, & McAfee, 2015; Modesto-Lowe & Alvarado, 2017; HHS, 2016) . Nicotine also has negative physiological effects on the respiratory, oral and/or dental, cardiovascular, gastrointestinal, and immune systems. Compared with adults, youth exposed to nicotine become addicted more easily, and dependence and withdrawal symptoms have been documented with brief exposures to low doses of nicotine (Goriounova & Mansvelder, 2012) . Youth who vape are nearly three times more likely to use other tobacco products (Berry et al., 2019) and are at increased risk for the use of other substances, including marijuana, opioids, and alcohol, and the future development of substance misuse disorders (National Academies of Sciences, Engineering, and Medicine, 2018). Tobacco product A product containing tobacco or a tobacco derivative. Nicotine A potentially addictive chemical derived from the leaves of tobacco plants. The act of breathing in the vapor form of nicotine or other substance from a vaping device. Devices can be refillable or disposable. Examples include e-cigarettes, ENDS, pods, pod mods, tanks, vape pens, or dab pens. E-cigarette An electronic device consisting of a vaporizing chamber, a solvent liquid chamber, and a small battery. The device rapidly heats, and then cools the liquid, creating an aerosol to be inhaled through a mouthpiece. It may also be called vape pen, e-hookah, e-cig, vape, or ENDS. Commercial e-cigarette pods A liquid containing tank or cartridge manufactured by a conventional tobacco company for use in a refillable e-cigarette device. Noncommercial e-cigarette pods A liquid containing product made by an independent company for use in refillable e-cigarette devices. Most commonly sold in "vape shops." May also be a product made for sale on the black market. Disposable vs. refillable A disposable e-cigarette is designed to be ready to use and then disposed of once empty. Refillable e-cigarettes contain a liquid containing tank or cartridge that needs to be changed or refilled when empty. A flavor additive to e-cigarette products, such as bubble gum, fruit, or mint. Additional ingredients added to the base liquid of an e-cigarette. The base liquid typically consists of propylene glycol, vegetable glycerol, or both. The most common commercial additives are nicotine and flavoring. Other potentially harmful additives may include formaldehyde, heavy metals, and other volatile chemicals. Cannabis (tetrahydrocannabinol or cannabidiol) or other unknown additives may be found in noncommercial products. E-Cigarette Aerosol, Secondhand Smoke (SHS), and Other Exposures E-cigarette aerosol contains higher concentrations of ultrafine particles, heavy metals, and volatile organic compounds than conventional tobacco smoke and is known to cause respiratory distress and disease (Fuoco, Buonanno, Stabile, & Vigo, 2014; Pellegrino et al., 2012) . As of February 2020, more than 2,800 individuals from the United States, Puerto Rico, and the U.S. Virgin Islands have been hospitalized for e-cigarette or vaping product use−associated lung injury with 68 confirmed deaths (Ellington et al., 2020) . Vaping products that contain tetrahydrocannabinol (THC) and vitamin E acetate have been strongly linked to the e-cigarette or vaping product use−associated lung injury. However, the evidence is insufficient to exclude the contribution of other chemicals of concern, including those in either THC or non-THC containing products (Blount et al., 2019; CDC, 2020a) . There is emerging evidence that vaping is harmful to lung health, is associated with more severe respiratory illness, and should be avoided (Centers for Disease Control and Prevention COVID-19 Response Team, 2020; National Academies of Sciences, Engineering, & Medicine, 2018; Truth Initiative, 2019). In the United States, 14 million children and 9.1 million adolescents are exposed to SHS at home, daycare, in public areas, and while riding in vehicles (Tsai et al., 2018) . SHS exposure increases the risk of ear infections, bronchitis, pneumonia, wheezing, and cough (HHS, 2014) . Children with asthma experience a greater number of asthma exacerbations and missed days from school (HHS, 2014) . SHS exposure alone has been linked to a higher incidence of depressive symptoms in adolescents (Jacob et al., 2020) . Additional hazards may exist from SH vape aerosol and should be avoided until evidence of the effects of long-term use is known (Visser et al., 2019) . Absorption of nicotine through the skin and mucous membranes can result in systemic toxicity (Hudson & Dotson, 2015) . Liquid nicotine and nicotine replacement products have been found to be a significant poisoning hazard to infants, young children, and adolescents through ingesting, handling, or misuse of these products (Govindarajan, Spiller, Casavant, Chounthirath, & Smith, 2018; Hudson & Dotson, 2015) . In response to a dramatic increase in calls to poison control centers nationwide for nicotine ingestion by young children, all liquid nicotine products must now be sold in childproof packaging (American Association of Poison Control Centers, 2019; Food and Drug Administration, U.S. Department of Health and Human Services, 2016). The National Association of Pediatric Nurse Practitioners (NAPNAP) strives to protect all children, adolescents, and young adults from the negative effects of exposure to tobacco products and nicotine through practice, health education, advocacy, policy, and research by advocating for the following recommendations. Routinely screen, infants, children, and adolescents for tobacco product exposure at every clinical encounter. Provide anticipatory guidance to youth and their adult caregivers on the risks associated with tobacco use, including the effects of nicotine on the developing brain. Provide counseling, developmentally appropriate cessation resources, and health care follow-up for any tobacco-using youth. Counsel youth and adult caregivers about the known risks of SHS, suspected risks of SH vapor, and safe storage to prevent accidental poisoning risk from ingestion or handling of nicotine-containing liquids. Incorporate content specific to tobacco product use, evidence-based screening, prevention, counseling, and cessation into the curricula at all levels of nursing education. Support public health education programs and campaigns that increase awareness of the unique health risks associated with youth tobacco product use. Support evidence-based curricula for school and community programs focused on the prevention of youth initiation of tobacco product use. Support evidence-based programs that promote healthy youth development, including positive coping and substance use refusal skills. Ban advertising of all tobacco products, including at point-of-sale. Remove all flavored tobacco products from the marketplace. Prohibit online sales of tobacco products. Support legislation to increase prices on all tobacco products through tax and nontax means, including taxation of e-cigarette products and devices at the same rate as other tobacco products. Support increased funding and the use of evidencebased strategies for comprehensive tobacco prevention and control at all levels of government. Support legislation that prohibits states from diverting funding provided for tobacco prevention to other purposes. Support clean air and smoke-free policies that prohibit smoking and vaping in all indoor and outdoor public spaces. Advocate for all school and university campuses to be smoke and vape-free. Support evidenced-based school discipline policies that provide access to tobacco education and referrals to counseling and treatment and are not disproportionately punitive and stigmatizing to nicotine-dependent youth. Support strict retailer accountability for age verification and enforcement of penalties for retailers who sell tobacco products to underage youth. Support limitations of nicotine concentration in e-cigarette products. Develop evidence-based guidelines for tobacco and nicotine prevention and cessation for youth and their caregivers. Examine the relationship between nicotine exposure and behavioral health issues among youth, including depression, anxiety, and suicidality, and the development of other substance misuse disorders and addiction. Investigate the short-and long-term health effects of vaping, particularly as it relates to lung health and respiratory illness. NAPNAP is a professional organization whose mission is "to empower pediatric-focused advanced practice registered nurses and key partners to optimize child and family health" (National Association of Pediatric Nurse Practitioners, 2020, p. 1). NAPNAP takes a strong stance against all tobacco product use and exposure. The prevention of tobacco use by youth is a critical issue that impacts the health and welfare of children, families, and communities. The initiation of tobacco use begins in childhood and adolescence; therefore, evidence-based prevention and cessation strategies are vital to avoiding lifelong nicotine dependence, as well as the known and unknown physiological and behavioral health consequences caused by the exposure to tobacco products throughout the life span. American Association of Poison Control Centers Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models Association of electronic cigarette use with subsequent initiation of tobacco cigarettes in US youths Evaluation of bronchoalveolar lavage fluid from patients in an outbreak of ecigarette, or vaping, product use-associated lung injury -10 states Outbreak of lung injury associated with the use of e-cigarette, or vaping, products The health effects of electronic cigarettes Vaping: The new wave of nicotine addiction Update: Product, substance-use, and demographic characteristics of hospitalized patients in a nationwide outbreak of e-cigarette, or vaping, product use-associated lung Injury -United States Deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; restrictions on the sale and distribution of tobacco products and required warning statements for tobacco products Influential parameters on particle concentration and size distribution in the mainstream of e-cigarettes Vital signs: Tobacco product use among middle and high school students -United States Levels of selected carcinogens and toxicants in vapour from electronic cigarettes Nicotine exposure during adolescence alters the rules for prefrontal cortical synaptic plasticity during adulthood E-cigarette and liquid nicotine exposures among young children The effects of nicotine on human fetal development NIOSH skin notation profiles: Nicotine. U.S. Department of Health and Human Services Secondhand smoking and depressive symptoms among in-school adolescents Flavored ecigarette use and progression of vaping in adolescents Electronic nicotine delivery systems marketing and initiation among youth and young adults E-cigs . . . are they cool? Talking to teens about e-cigarettes Monitoring the Future Survey results show alarming rise in teen vaping Popular flavors used in alternative tobacco products among young adults Electronic cigarettes: An evaluation of exposure to chemicals and fine particulate matter (PM) Public health consequences of e-cigarettes E-cigarettes: Facts, stats and regulations Exposure to secondhand smoke among nonsmokers -United States Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion E-cigarette use among youth and young adults. A report of the surgeon general The health risks of electronic cigarette use to bystanders Tobacco product use and associated factors among middle and high school students -United States The use of electronic cigarettes in pregnancy: A review of the literature Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol Adverse effects of perinatal nicotine exposure on reproductive outcomes Nicotine and the adolescent brain